A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humansMatilu Mwau, Tomáš Hanke, Julian Sutton et al.|Journal of General Virology|2004Cited by 210
Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85AKathryn T. Whelan, Helen McShane|PLoS ONE|2009Cited by 72